Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ANTHONY R MATO

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1053473983
CMS profile
228930
Location
ITHACA, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$38,296.42

45 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

By paying entity

PY2022 · entire year · sorted by reported total

Paying entityAmountRecords
E.R. Squibb & Sons, L.L.C. $8,650.00 4
Genentech, Inc. $8,011.97 5
BeiGene USA, Inc. $5,200.00 2
TG Therapeutics, Inc. $4,153.45 3
Lilly USA, LLC $2,400.00 1
AstraZeneca Pharmaceuticals LP $2,337.12 6
ABBVIE INC. $1,919.58 8
Janssen Biotech, Inc. $1,574.90 2
Janssen Global Services, LLC $1,550.00 1
Pharmacyclics LLC, an AbbVie Company $1,240.74 4
Eli Lilly and Company $959.25 5
Seagen Inc. $299.41 4

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

45 matching records · $38,296.42 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 45 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–45 of 45.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AstraZeneca Pharmaceuticals LP $1,712.5012/21/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026914909657 CMS
Eli Lilly and Company $659.0412/12/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261091173970 CMS
Genentech, Inc. $660.0012/12/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026950809429 CMS
Seagen Inc. $42.6612/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026904100217 CMS
AstraZeneca Pharmaceuticals LP $135.0012/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026914905179 CMS
AstraZeneca Pharmaceuticals LP $55.0012/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026914977653 CMS
ABBVIE INC. $111.7612/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026891116015 CMS
AstraZeneca Pharmaceuticals LP $42.6712/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026914648121 CMS
Eli Lilly and Company $103.3512/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026917881499 CMS
AstraZeneca Pharmaceuticals LP $266.9110/25/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026914721615 CMS
Pharmacyclics LLC, an AbbVie Company $550.0010/10/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026890343851 CMS
ABBVIE INC. $1,375.0010/07/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026891116013 CMS
Seagen Inc. $146.6509/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026904100189 CMS
E.R. Squibb & Sons, L.L.C. $2,768.0009/19/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026932631717 CMS
Pharmacyclics LLC, an AbbVie Company $550.0009/01/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026890343849 CMS
Genentech, Inc. $660.0008/25/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026950809975 CMS
ABBVIE INC. $124.0207/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026891116011 CMS
E.R. Squibb & Sons, L.L.C. $1,384.0007/20/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026932631703 CMS
Eli Lilly and Company $43.0407/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026917881127 CMS
Seagen Inc. $72.1207/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026904100131 CMS
Janssen Global Services, LLC $1,550.0007/11/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026887128683 CMS
BeiGene USA, Inc. $3,250.0007/01/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026940796105 CMS
Janssen Biotech, Inc. $1,550.0006/27/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026886463491 CMS
Seagen Inc. $37.9806/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026904100127 CMS
Pharmacyclics LLC, an AbbVie Company $35.6006/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026890343847 CMS
Genentech, Inc. $91.9706/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026950767699 CMS
ABBVIE INC. $77.7706/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026891116007 CMS
ABBVIE INC. $10.3606/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026891116009 CMS
Eli Lilly and Company $35.9206/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026917881495 CMS
ABBVIE INC. $19.5606/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026891116005 CMS
Eli Lilly and Company $117.9006/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026917881491 CMS
Pharmacyclics LLC, an AbbVie Company $105.1406/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026890343845 CMS
ABBVIE INC. $105.2006/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026891116003 CMS
Janssen Biotech, Inc. $24.9005/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026886463497 CMS
Lilly USA, LLC $2,400.0004/01/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026917877729 CMS
Genentech, Inc. $3,300.0003/28/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026950810395 CMS
BeiGene USA, Inc. $1,950.0003/24/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026940796103 CMS
AstraZeneca Pharmaceuticals LP $125.0403/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026914911905 CMS
E.R. Squibb & Sons, L.L.C. $1,384.0003/10/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026932631671 CMS
ABBVIE INC. $95.9102/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026891116001 CMS
TG Therapeutics, Inc. $44.5402/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026940839845 CMS
TG Therapeutics, Inc. $58.9102/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026940839849 CMS
E.R. Squibb & Sons, L.L.C. $3,114.0002/08/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026932631669 CMS
TG Therapeutics, Inc. $4,050.0001/31/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026940839757 CMS
Genentech, Inc. $3,300.0001/28/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026950690747 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $76,103.96 74
PY2020 $42,038.34 22
PY2021 $59,334.31 45
PY2022 $38,296.42 45
PY2023 $154,970.26 18
PY2024 $228,014.59 21
PY2025 $310,487.20 11

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
ANTHONY R MATO, NPI 1053473983. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1053473983.
APA 7
IndustryPayments. (2026). ANTHONY R MATO, NPI 1053473983 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1053473983
Bluebook
ANTHONY R MATO, NPI 1053473983, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1053473983.

Source: Centers for Medicare & Medicaid Services, Open Payments.